Bortezomib 70511-0162-02

Package NDC

70511-0162-02

Manufacturer: Maia Pharmaceuticals, Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 10, 2022
Listing Expires: December 31, 2026
Application: NDA215331

Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Bortezomib	2.5 mg/1

Drug Class

Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]

Selected Package

70511-0162-02Selected

1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-162-02)